Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARTUM: Aspirin for Postpartum VTE Prevention
NCT04153760Phase 1Completed
- Sponsor
- University of Calgary
- Start
- Oct 2020
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Phase 1, randomised, double-blind trial in venous thromboembolism (VTE) comparing Aspirin with Placebo (2 arms). Primary endpoint: Recruitment Rate at 6 months. Started Oct 2020; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT04153760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04153760.